← Back to Search

Other

BTL-785-7 Treatment for Wrinkles

N/A
Waitlist Available
Research Sponsored by BTL Industries Ltd.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 months
Awards & highlights

Study Summary

This trial will study whether a new non-invasive facial treatment system is safe and effective in patients injected with botulinum toxin. The goal is to see if the system improves overall facial appearance and muscle tone.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Facial Appearance Change
Secondary outcome measures
Facial expression assessment
Subject Satisfaction
Therapy Comfort

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: BTL-785-7 TreatmentExperimental Treatment1 Intervention
Subjects will be enrolled for an active treatment with BTL-785F device (BTL-785-7 applicator) for improvement of overall facial appearance and muscle tone in patients injected with botulinum toxin.
Group II: ControlActive Control1 Intervention
Two (2) patients will be enrolled in the control group study and will not receive any treatment. Following the completion of the investigation, the control group patients will be offered the same treatment course as the active group.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
BTL-785-7 Treatment
2022
N/A
~20

Find a Location

Who is running the clinical trial?

BTL Industries Ltd.Lead Sponsor
51 Previous Clinical Trials
1,789 Total Patients Enrolled
12 Trials studying Wrinkles
364 Patients Enrolled for Wrinkles

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the enrollment phase of this study still active?

"According to the information listed on clinicaltrials.gov, this medical trial is not currently enrolling patients. Although it was originally posted on July 6th 2022 and last updated September 1st 2022, participants are no longer being sought out for recruitment at this time. However, there are 20 additional studies actively seeking volunteers right now."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
BTL-785F Device for Non-invasive Facial Rejuvenation in Patients Injected With Botulinum Toxin
2022. "BTL-785F Device for Non-invasive Facial Rejuvenation in Patients Injected With Botulinum Toxin". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05524766.
~5 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top